Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic Patients

NCT07165821 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-09-10

No results posted yet for this study

Summary

This quasi-experimental two-group pretest-posttest study examined the effects of an interpersonal communication skills training program on medication adherence in patients with schizophrenia, measured at pre-intervention, post-intervention, and one-month follow-up.

Research Hypotheses

1. The experimental group receiving the interpersonal communication skills training program will show higher mean treatment adherence scores post-intervention and at one-month follow-up compared to baseline.
2. The experimental group will show higher mean treatment adherence scores post-intervention and at one-month follow-up than the control group receiving routine nursing care.

Conditions

  • Schizophrenia; Psychosis
  • Remission
  • Non-Adherence, Medication

Interventions

BEHAVIORAL

Interpersonal Communication Skills Training Program

This program was developed based on DeVito's communication theory and integrated with the positive reinforcement-based interpersonal communication training developed by Thiengwiriyakul et al.(11) This program was evaluated by a panel of three experts-a psychiatrist, a psychiatric nurse, and a psychiatric nursing academic-who assessed content relevance, appropriateness, and language clarity. After revisions based on their feedback, the program achieved a Content Validity Index (CVI) of 0.93, exceeding the acceptable threshold.

BEHAVIORAL

Usual care

Received routine psychiatric nursing care

Sponsors & Collaborators

  • Suranaree University of Technology

    lead OTHER

Principal Investigators

  • Arunee Roongrusamee, Dip.N.S. · Prasrimahabhodi Psychiatric Hospital, Ubon Ratchathani, 34000, Thailand

  • Palida Phalasak, M.N.S · Prasrimahabhodi Psychiatric Hospital, Ubon Ratchathani, 34000, Thailand

  • Aungkhana Chaiyarak, Dip.N.S. · Prasrimahabhodi Psychiatric Hospital, Ubon Ratchathani, 34000, Thailand

  • Sakda Khumkom, Ph.D. · Institute of Nursing, Suranaree University of Technology, Nakhon Ratchasima, 30000, Thailand

  • Thanakamon Leesri, Ph.D. · Institute of Nursing, Suranaree University of Technology, Nakhon Ratchasima, 30000, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
59 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07165821 on ClinicalTrials.gov